Who profited from the so-called pandemic of H1N1 flu? Why drug companies, of course.
So far, the dreaded flu has killed a confirmed 14,711 around the world. The exact total in the U.S. is unclear, with the Centers for Disease Control and Prevention confirming 4,000 deaths, but estimating up to 16,500 in case of underreporting. These numbers are not only smaller than what was predicted but also are far less than the normal mortality rate for ordinary flu seasons.
The one thing that was up last year was earnings for makers of H1N1 vaccines. CSL Limited saw its profits rise 63% above 2008 levels by June 2009, while GlaxoSmithKline enjoyed a 30% jump by the third quarter. Roche, maker of the preventive Tamiflu, enjoyed a twelve fold leap in profits from the second quarter of 2008 to the same period in 2009.
These would be the same folks that the Obama administration cut a sweetheart deal with to get them on board his health care “reform”.
Was this the change you were hoping for? Big payouts for the drug companies?